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ORIGINAL ARTICLEComparative genomics of Neisseria meningitidis strains: new targets for
molecular diagnosticsS. M. Diene1, C. Bertelli1, T. Pillonel1,2, N. Jacquier1, A. Croxatto1, K. Jaton1 and G. Greub1
1) Institute of Microbiology, University Hospital Center and University of Lausanne and 2) SIB Swiss Institute of Bioinformatics, Lausanne, SwitzerlandAbstractIn 2010, Jaton et al. (False-negative PCR result due to gene polymorphism: the example of Neisseria meningitidis. J Clin Microbiol
2010;48:4590–2) reported an isolate of Neisseria meningitidis serogroup B that was not detected by the ctrA quantitative real-time PCR
(qRT-PCR) used in our diagnostic laboratory. Sequence analysis of ctrA revealed several single nucleotide polymorphisms responsible for
the negative qRT-PCR. Therefore, we sequenced the genome of this isolate and performed comparative genomics to propose new gene
targets for the speciﬁc detection of N. meningitidis from clinical specimens. We identiﬁed 11 genes as speciﬁc to N. meningitidis genomes
and common to at least 177 (97%) of the 183 genomes available. Among them, three genes (metA, tauE and shlA) were selected to
develop new qRT-PCRs for the detection of N. meningitidis DNA. The three qRT-PCRs were highly sensitive and speciﬁc, and they
exhibited a good reproducibility when tested on plasmidic positive controls and genomic DNA extracted from strains of N. meningitidis
and other relevant bacterial species. The clinical sensitivity and speciﬁcity of metA and tauE qRT-PCRs were both 100% based on a testing
of cerebrospinal ﬂuid samples positive for N. meningitidis or other clinically relevant bacteria. Despite a 100% speciﬁcity, the sensitivity of
the shlA qRT-PCR was only 70%. We thus recommend using the metA and/or tauE qRT-PCRs developed here. To prevent PCR failure in
the presence of new polymorphic strains, the detection of dual targets by duplex qRT-PCR would be more accurate and suitable for the
diagnosis of N. meningitidis from clinical specimens.
© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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E-mail: gilbert.greub@chuv.chIntroductionBacterial meningitis, a severe infection affecting the central
nervous system [1,2], is mainly caused by three bacteria:
Streptococcus pneumoniae, Haemophilus inﬂuenzae type b and
N. meningitidis. N. meningitidis causes invasive meningococcal
infections including meningitis and septicaemia, which areMicrobiol Infect 2016; 22: 568.e1–568.e7
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p://dx.doi.org/10.1016/j.cmi.2016.03.022life-threatening diseases requiring prompt treatment with an
appropriate antibiotic [1]. N. meningitidis is frequently localized
in the nasopharynx [3,4], and its carriage rate in the nasopha-
ryngeal cavity varies from 5 to 10% of adolescents and young
adults [5]. Mortality associated with N. meningitidis remains— it
is about 10% in industrialized countries—despite modern
healthcare management. Moreover, morbidity may include
long-term sequelae such as hearing loss, cognitive dysfunction,
developmental delay and motor nerve deﬁcits [6]. Twelve
serogroups of N. meningitidis have been identiﬁed on the basis of
the capsular polysaccharide structures, and among them six
serogroups (A, B, C, W, X and Y) are the major causes of
severe invasive disease [4,7–9].
Before the availability of PCR-based testing, diagnosis of
N. meningitidis infections was mainly performed by bacterialiology and Infectious Diseases
nses/by-nc-nd/4.0/)
CMI Diene et al. Comparative genomics of N. meningitidis 568.e2culture, which is relatively slow, as it requires approximately 24
to 48 hours for a conﬁrmed positive result. Moreover, prior
antibiotic therapy affects the results of conventional bacterio-
logic methods, including bacterial culture, decreasing the
detection rate of the pathogenic bacteria by approximately 30%
[10]. In addition to the low sensitivity of culture, errors in
phenotypic identiﬁcation may occur, even when matrix-assisted
laser desorption/ionization time-of-ﬂight mass spectrometry
(MALDI-TOF MS) technology [11] is used. Indeed, Cunningham
et al. [12] recently reported the misidentiﬁcation of
N. polysaccharea strains as N. meningitidis using MALDI-TOF MS
with high identiﬁcation scores ranging from 2.068 to 2.241.
Such misidentiﬁcation is expected because these two species
are closely related, as demonstrated by their high percentage of
16S rRNA identity (99.3%).
During the last 20 years, the diagnosis of bacterial meningitis
has been improved by the development of PCR assays that
speciﬁcally target the responsible pathogens. To this end,
Corless et al. [2] described in 2001 quantitative real-time PCR
(qRT-PCR) assays targeting the ply, bexA and ctrA genes for
detection of S. pneumoniae, H. inﬂuenzae and N. meningitidis,
respectively. Therefore, several diagnostic laboratories,
including our own, used the ctrA gene as a target for the
detection of N. meningitidis from clinical samples and especially
from cerebrospinal ﬂuid (CSF) specimens. However, some
studies reported that the chromosomal locus containing the
ctrA gene could be subject to rearrangement, and hence 16 to
28% of N. meningitidis isolates lack the ctrA gene [13–15]. Thus,
targeting this gene can lead to false-negative detection of N.
meningitidis. Importantly, we recently had a case of
N. meningitidis meningitis in a 2-year-old child conﬁrmed by
culture, for which the PCR was negative due to the presence of
several single nucleotide polymorphisms (SNPs) in the ctrA gene
at the binding positions of the reverse primer and the probe
[16]. A similar false-negative result of the ctrA qRT-PCR was
also documented in Italy [17].
Given the need for accurate tools to diagnose this major
pathogen, we describe here the genome sequence of the
N. meningitidis isolate reported by Jaton et al. [16] and provide a
detailed comparative genomic analysis to identify new target genes.
We developed three new quantitative real-time PCRs for speciﬁc
diagnosis ofN.meningitidis species and evaluated their performance
using genomic DNA from isolates and clinical samples.Materials and MethodsIsolate
The N. meningitidis CHUV (Nm CHUV) isolate under investi-
gation was cultured from a CSF sample taken from a 2-year-old© 2016 The Authors. Published by Elsevier Ltd on behalf of Eu
This is an open access articchild hospitalized at the University Hospital Center of Lausanne
for meningitis with petechiae [16].
Genome sequencing
Genomic DNA was extracted and puriﬁed using the Wizard
Genomic DNA puriﬁcation kit (Promega, Duebendorf,
Switzerland). Genomic libraries were constructed using the
Nextera XT library kit (Illumina, San Diego, CA, USA) in order
to combine different genomic projects in the same sequencing
run. Constructed libraries were normalized on speciﬁc beads
according to the Nextera XT protocol and pooled into a single
library for paired-end sequencing of 2 × 150 bp using the MiSeq
(Illumina).
Genome assembly and annotation
The reads were ﬁltered based on their quality and size using the
fastq-mcf program (Ea-utils: http://code.google.com/p/ea-utils).
Genome assembly was done using the SPAdes assembler with
different kmer values (from 81 to 127). The assembly with
lowest number of contigs and highest N50 was selected for
further analysis. To perform genomic comparison, we retrieved
from the National Center for Biotechnology Information
(NCBI) database all complete (n = 14) and incomplete (n = 169)
genomes of N. meningitidis, as well as 14 non-meningitidis Neis-
seria genomes including N. gonorrhoeae, N. cinerea, N. bacilli-
formis, N. elongata, N. ﬂavescens, N. lactamica, N. macacae, N.
mucosa, N. polysaccharea, N. sicca, N. subﬂava, N. wadsworthii, N.
weaveri and an unclassiﬁed Neisseria strain. The genome of the
Nm CHUV isolate, as well as the 14 complete genomes of
N. meningitidis and the 14 non-meningitidis Neisseria genomes,
were reannotated using the RAST Server [18]. To identify the
multilocus sequence typing (MLST) proﬁle, the Nm CHUV
genome was submitted to the pubMLST database (http://www.
pubMLST.org).
Genomics comparison to identify new target genes for
diagnostic qRT-PCR
Pairwise genome sequence identities were calculated by the
JSpecies program (http://www.imedea.uib.es/jspecies). After
annotation, the gene pool of Nm CHUV was compared by
BLASTN with those of all non-meningitidis (cutoffs: gene
coverage > 40%, E value <10−3) to identify genes speciﬁc to Nm
CHUV. The latter were subjected to a reciprocal BLASTN with
all N. meningitidis gene pools (n = 35 628 genes) to identify genes
common to the 14 N. meningitidis genomes. This subset of
common N. meningitidis genes was subsequently subjected to a
BLASTN similarity search against the National Center for
Biotechnology Information (NCBI) nonredundant database ‘nt.’
Genes speciﬁc to N. meningitidis species and common to all
N. meningitidis complete genomes were kept. Finally, theropean Society of Clinical Microbiology and Infectious Diseases, CMI, 22, 568.e1–568.e7
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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whole genome shotgun sequences of N. meningitidis. From the
speciﬁc and conserved genes within the 183 available genomes
of this species, three genes were selected for the development
of new speciﬁc qRT-PCRs because of their presence in all 183
genomes analysed and their predicted function based on the
hypothesis that a gene with a key function is less likely to be lost
throughout evolution.Quantitative real-time PCR development
Primers and probes targeting the genes of interest were
designed using Primer3 0.4.0 software [19]. The speciﬁcity of
the primers and probes was checked by BLASTN against the
nonredundant NCBI database and by in silico PCR from the
online database (http://insilico.ehu.es/). Targeted gene se-
quences (about 500 bp) containing the qRT-PCR primer and
probe sequences were ampliﬁed by PCR using primers
described in this study. PCR products were puriﬁed and cloned
into a pCR2.1-TOPO vector (Thermo Fisher Scientiﬁc Life
Sciences, Waltham, MA, USA) as previously described [20]. The
recombinant control plasmids were produced in Escherichia coli
TOP10 competent cells and quantiﬁed using a Nanodrop ND-
1000 (Witech, Littau, Switzerland). Several tenfold dilutions
were performed to prepare plasmid solutions from 105 copies/
μL to 1 copy/μL. In addition, primers and probe solutions were
tested at two concentrations (100 nM, 200 nM) to determine
the optimal concentrations for the qRT-PCR assays that were
always performed with 5 μL of template DNA in a ﬁnal volume
of 20 μL, as previously described [20]. The DNA ampliﬁcation
and quantiﬁcation was performed on a StepOne instrument
(Thermo Fisher Scientiﬁc Life Sciences) with the following
conditions: a holding stage (50°C for 2 minutes and 95°C for
10 minutes) followed by a cycling step repeated 40 times (95°C
for 1 second and 60°C for 20 seconds).
To evaluate the efﬁciency, analytical sensitivity and repro-
ducibility of the qRT-PCRs, each primer concentration was
tested with each probe concentration on a dilution series of the
control plasmid. The analytical speciﬁcity was tested on 29
extracted genomic DNAs of reference and clinical isolates
(collected from our clinical diagnostic laboratory) including
N. meningitidis (n = 5), other Neisseria species (N. gonorrhoeae
(n = 3), N. elongata (n = 2), N. ﬂavescens (n = 4), N. mucosa
(n = 3), N. bacilliformis (n = 1), N. weaveri (n = 1), N. lactamica
(n = 1), N. canis (n = 1), N. zoodegmatis (n = 1), Neisseria sp.
(n = 2)) and organisms not belonging to the Neisseria genus
(E. coli (n = 1), Staphylococcus aureus (n = 1), Pseudomonas aer-
uginosa (n = 1), H. inﬂuenzae (n = 1) and Streptococcus mitis
(n = 1)). All genomic DNA concentrations were standardized
to 104 DNA copies/μL. The speciﬁcity of our three qRT-PCRs
was also determined using clinical CSF samples positive for© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
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H. inﬂuenzae type b (n = 1) and c (n = 1) and Enterococcus
faecalis (n = 5). The sensitivity was also tested on CSF samples
positive for N. meningitidis (n = 10), by tenfold dilution, in
duplicate, until negativity. These ten N. meningitidis strains
belonged to serotypes W135/Y (n = 3), serotype C (n = 2),
serotype B (n = 1) and undetermined serotypes (n = 4). Sterile
DNA-free water was used as negative control.ResultsGenome analysis
Genome assembly of the 2 044 080 paired reads from isolate
Nm CHUV produced 144 contigs with lengths ranging from
1008 to 95 448 bp and an average contig size of 14 940 bp. The
genome size was estimated to be 2 151 415 bp with a GC
content of 51.65% and coverage of 142 fold. No plasmids were
identiﬁed. Table 1 summarizes the general features of the Nm
CHUV genome and the published complete genomes of
N. meningitidis strains, which belong to different serogroups
including A, B and C as well as one that was nongroupable.
Almost all were isolated from Europe, except one each from
China, the United States and the Gambia in Africa. Genome
comparison of this Nm CHUV isolate with the 14 available
complete genomes of N. meningitidis (Table 1) revealed that this
isolate is most similar to the N. meningitidis M04-240196 isolate,
with 99.72% average nucleotide identity. Pairwise nucleotide
identity with the other 13 complete N. meningitidis genomes
ranged between 97.10 and 97.83% (Table 1).
As expected, sequence analysis of the ctrA gene obtained by
whole genome sequencing conﬁrmed the existence of SNPs in
the Nm CHUV isolate. One SNP (G to A) was located on the
probe sequence, and four SNPs (A, T, A, G to G, G, C, G,
respectively) were located on the reverse primer sequence.
Interestingly, the recently described Nm M04-240196 isolate
exhibits exactly the same SNPs in the ctrA gene. MLST results
(abcZ 4, adk 10, aroE 15, gdh 8, pdhC 11, pgm 9, fumC unknown)
show that the isolate Nm CHUV belongs to clonal complex
269, which is represented by the type strain M04-240196.
However, it cannot be classiﬁed to a known sequence type
because it harbours an unknown fumC allele (no known allele
type assigned). Moreover, strain M04-240196 and CHUV differ
by 777 SNPs along the genome sequence.
Gene pool comparison of the Nm CHUV genome (n = 2602
genes) with those of 16 genomes of non-meningitidis species
(n = 55 038 genes) by BLASTN identiﬁed 129 genes that are spe-
ciﬁc to the genome of the NmCHUV isolate. Reciprocal BLASTN
comparison of these speciﬁc genes with the 14 complete genomes
of N. meningitidis revealed that 23 of these 129 unique genes areiology and Infectious Diseases, CMI, 22, 568.e1–568.e7
nses/by-nc-nd/4.0/).
TABLE 1. General features of Neisseria meningitidis CHUV genome and the published complete genomes of 14 additional
N. meningitidis isolates
Organism BioProject Size (Mb) GC% Genes Proteins Serogroup Geographic origin
% of genome
identitya
Neisseria meningitidis CHUV — 2.15 51.65 2657 2602 B Switzerland —
Neisseria meningitidis MC58 PRJNA57817 2.27 51.5 2675 2602 B United Kingdom 97.83
Neisseria meningitidis M01-240355 PRJNA162075 2.29 51.5 2667 2596 B United Kingdom 97.32
Neisseria meningitidis 053442 PRJNA58587 2.15 51.7 2550 2479 C China 97.22
Neisseria meningitidis 8013 PRJEA161967 2.28 51.4 2660 2589 C France 97.19
Neisseria meningitidis FAM18 PRJNA57825 2.19 51.6 2557 2486 C United States 97.40
Neisseria meningitidis G2136 PRJNA162085 2.18 51.7 2600 2529 B United Kingdom 97.19
Neisseria meningitidis H44/76 PRJNA162083 2.24 51.4 2097 2538 B Norway 97.19
Neisseria meningitidis M01-240149 PRJNA162079 2.22 51.4 2609 2545 B United Kingdom 97.19
Neisseria meningitidis M04-240196b PRJNA162081 2.25 51.4 2627 2555 B United Kingdom 99.72
Neisseria meningitidis NZ-05/33 PRJNA162077 2.25 51.3 2634 2563 B New Zealand 97.19
Neisseria meningitidis WUE 2594 PRJEA162093 2.23 51.8 2691 2624 A Germany 97.10
Neisseria meningitidis Z2491 PRJNA57819 2.18 51.8 2578 2508 A Gambia 97.05
Neisseria meningitidis alpha14 PRJNA61649 2.15 51.9 2512 2442 cnl Germany 97.19
Neisseria meningitidis alpha710 PRJNA161971 2.24 51.7 2650 2580 B Germany 97.36
aPercentage of identity of the genome of the N. meningitidis CHUV strain with the published genomes of other N. meningitidis isolates, calculated by the JSpecies program (using
BLAST and Nucmer programs); cnl, capsule null locus.
bThis single genome exhibited more than 99% average nucleotide identity.
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BLASTN analysis against the nonredundant database to remove
those present in other bacteria. Finally, the presence of 11 genes
unique toN. meningitidiswas investigated in the 169 draft genomes
of N. meningitidis (incomplete genomes) available. Taken together,
these analyses allowed us to identify 11 genes that were speciﬁc to
N. meningitidis and common to more than 97% of the 183 available
genomes (Supplementary Table S1). These 11 genes encode pro-
teins involved in bacterialmembrane structure, the toxin/antitoxin
system or export/import metabolism. Three of these 11 genes,
present in all 183 N. meningitidis genomes, were selected as po-
tential targets for the development of qRT-PCR assays for the
diagnosis of N. meningitidis: metA, encoding a periplasmic protein
associated with the phenol degradation pathway; tauE, encoding a
sulphite exporter; and shlA, encoding a putative large exoprotein
involved in haeme utilization or in adhesion.
Quantitative real-time PCR assays
The primer and probe sequences for the three quantitative and
standard PCRs are listed in Table 2. The optimal concentrations
of primers and probes for the qRT-PCRs were estimated at 200
and 100 nM, respectively, for the primer and probe solutions
(data not shown).
The efﬁciency of the three qRT-PCRs was tested on control
plasmidswith differentDNAcopy numbers.Weobserved a good
correlation between DNA copy number and cycle threshold (Ct)
values for all three targets:metA (R2 = 0.9946; slope, −3.88), tauE
(R2 = 0.9951; slope, −3.67) and shlA (R2 = 0.9945; slope, −3.80).
Control plasmids, at a concentration of 5 × 105 DNA copies/
reaction, were detected for metA, tauE and shlA at Ct values of
17.45 ± 0.149, 17.17 ± 0.09 and 16.54 ± 0.05, respectively,
whereas the concentration of 5 DNA copies/reaction was
detected at Ct values of 36.49 ± 0.663, 35.01 ± 0.584 and© 2016 The Authors. Published by Elsevier Ltd on behalf of Eu
This is an open access artic35.43 ± 0.919, respectively. Evaluation of the analytical sensitivity
for the three targets showed 100% positive detection at a con-
centration of ten DNA copies per reaction and 80% positive
detection at a concentration of ﬁve DNA copies per reaction
(Fig. 1). In the presence of fewer than ﬁve DNA copies, detection
was variable for the three targets. The reproducibility of the three
qRT-PCRs was evaluated with ten replicates of each control
plasmid (Fig. 1). The speciﬁcity testing revealed positive ampliﬁ-
cation with Ct values 23.63 for all 5 N. meningitidis isolates and
negative results for the other bacteria tested.
The clinical speciﬁcity using the PCR advance kit of these
qRT-PCRs tested on CSF samples revealed 100% speciﬁcity for
tauE, metA and shlA. Indeed, when CSF positive for other bac-
teria were tested, no DNA was ampliﬁed. The clinical sensitivity
of metA and tauE qRT-PCRs was excellent (100%), comparable
to that of the ctrA qRT-PCR used here as the reference stan-
dard, whereas shlA was only detected in 70% of
N. meningitidis–positive samples tested.DiscussionRapid and accurate identiﬁcation of pathogenic bacteria
responsible for severe infections is crucial for a quick, adequate
and efﬁcient treatment. This holds especially true for bacterial
infections caused by N. meningitidis such as septicaemia and
meningitis that are serious causes of morbidity and mortality.
Here we report a comparative genomic approach to identify
genes conserved and speciﬁc to N. meningitidis species, and we
develop new qRT-PCRs for the speciﬁc detection of this
pathogen.
New molecular diagnostic approaches such as qRT-PCR
assays have revolutionized the hospital practices in theropean Society of Clinical Microbiology and Infectious Diseases, CMI, 22, 568.e1–568.e7
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
TABLE 2. Primers and probes designed and validated in this study
Gene name Primer and probe name Sequence Product size (bp)
Primers and probes for quantitative PCR assay
tauE tauE-F TTTCCGATGCTCGGTACAACC 81
tauE-R CAGGCTTGGTAATGCCACCA
tauE-Probe 6FAM-TCATGCCATTGTCTAAGGTTGTTGCCT
metA metA-F GCGAATTTGCTAATCCTATTTATGTGC 94
metA-R AAATTTTGCGCCATTACAGGTG
metA-Probe 6FAM-AACCAGCGCAACGAAAATTGCAA
shlA shlA-F CCATGGTTGCAGTAGCCGAAA 99
shlA-R CGCAAAGGTCGCCTGAAGTT
shlA-Probe 6FAM-TGCCAACAGCCAGGGCAAAGG
Primers for standard PCR and cloning
tauE tauE-VF TGCAATCTATCGTTTTTGTTGC 660
tauE-VR TCCTTAACCGAATTCCAACAT
metA metA-VF CCAGCCAAATTGCTTATGCT 509
metA-VR GTGCATGAATACCCGGTCTC
shlA shlA-VF TGAATAAAGGTTTACATCGCATT 508
shlA-VR ATAATCACGTCGGCCTTTTG
metA, gene encoding a periplasmic protein named MetA; shlA, gene encoding a putative large exoprotein involved in haeme utilization or in adhesion (part of the ShlA/HecA/FhaA
family); tauE, gene encoding the sulphite exporter protein TauE/SafE.
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phenotypic methods including bacterial culture or Gram
staining, these methods signiﬁcantly reduce the time for bac-
terial identiﬁcation from about 24 hours to 2.5 hours [12].
However, in the case of N. meningitidis, some concerns have
emerged about the genes targeted by qRT-PCRs currently
available for diagnostic laboratories. First, the ctrA gene has
been reported to be absent in up to 60% of nongroupable
strains, generally associated with nasopharyngeal carriage [22].
Moreover, the ctrA gene was reported to exhibit several SNPs
in the regions targeted by the primers and probes for qRT-PCR
[16]. Both the lack of ctrA and the presence of polymorphisms
in the gene may lead to false-negative results. The sodC gene has
been described as an alternative target for identiﬁcation of
N. meningitidis strains, especially for those lacking the capsule
[13]. However, sodC was proposed to be acquired by
N. meningitidis by horizontal gene transfer from H. inﬂuenzae
[13,23], suggesting inadequate speciﬁcity with possible cross-
detection of H. inﬂuenzae. Moreover, we showed by compar-
ative genomics that this gene was not conserved in and not
speciﬁc to all 183 N. meningitidis genomes analysed in this study.
The comparative genomics approach used in this study
identiﬁed 11 genes speciﬁc and common to more than 97% of
N. meningitidis genomes. Among these, three genes were
selected to develop three diagnostic qRT-PCRs. These three
new qRT-PCRs showed high analytical sensitivity and repro-
ducibility when tested on N. meningitidis plasmid positive con-
trol and good speciﬁcity when tested on genomic DNA
extracted from bacterial strains involved in meningitis
(S. pneumoniae and H. inﬂuenzae) or important pathogens
(P. aeruginosa, E. coli and S. aureus). Both qRT-PCRs for metA
and shlA detection were speciﬁc for N. meningitidis because all
ampliﬁcations were negative on clinical samples previously© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licepositive for other bacteria. Clinical sensitivity was excellent for
the metA and tauE qRT-PCRs, whereas the shlA qRT-PCR
exhibited a 70% clinical sensitivity. However, we were not
able to test these qRT-PCRs using representative isolates of all
N. meningitidis serogroups, and thus our results may not be
generalizable for all serogroups at this time.
ShlA, ctrA and sodC appear to be suboptimal targets for
diagnostic PCR, whereas our metA and tauE qRT-PCR assays
represent a good alternative and sensitive targets for the
detection of N. meningitidis from clinical samples. The occur-
rence of SNPs or gene loss of the targeted genes in some
N. meningitidis isolates cannot be excluded. Thus, we believe
that combining metA and tauE qRT-PCRs or combining metA
qRT-PCRs with the widely used ctrA qRT-PCR for the diag-
nosis of this important pathogen may avoid any misidentiﬁ-
cation or false-negative results that may have severe
consequences for the patient. The future development of a
duplex or triplex PCR that detects multiple targets— i.e. both
the metA and tauE genes—will improve the detection efﬁ-
ciency of N. meningitidis.
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FIG. 1. Analytic sensitivity and reproducibility of three quantitative real-time PCRs. Analytic sensitivity was evaluated using each control plasmid
(pmetA, ptauE, pshlA) with ten replicates of seven different concentrations of plasmid DNA (0.5, 1, 3, 5, 10, 25 and 50 copies per reaction).
Reproducibility was evaluated using same control plasmids with ten replicates of four different concentrations of DNA plasmid (10, 25, 50 and 100
copies per reaction).
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